We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+9.53%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$20.6B
AUM Growth
+$1.31B
(+6.8%)
Cap. Flow
-$24.4M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
23.17%
Holding
1,324
New
114
Increased
401
Reduced
595
Closed
142
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
US Bancorp
USB
|
+$107M |
| 2 |
PayPal
PYPL
|
+$95.5M |
| 3 |
PepsiCo
PEP
|
+$94.2M |
| 4 |
Bank of America
BAC
|
+$88.1M |
| 5 |
UnitedHealth
UNH
|
+$87.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$138M |
| 2 |
Microsoft
MSFT
|
+$92.2M |
| 3 |
Public Storage
PSA
|
+$88.3M |
| 4 |
Qualcomm
QCOM
|
+$85.2M |
| 5 |
Robert Half
RHI
|
+$76.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.95% |
| 2 | Healthcare | 15.44% |
| 3 | Financials | 14.85% |
| 4 | Consumer Discretionary | 10.89% |
| 5 | Consumer Staples | 8.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
726
Berkshire Hathaway Class A
BRK.A
$1.09T
| $937K | ﹤0.01% |
2
| – | – |
|
|
DSKE
727
DELISTED
Daseke, Inc. Common Stock
DSKE
| $936K | ﹤0.01% |
164,525
-24,596
| -13% | -$145K |
|
728
Repligen
RGEN
$9.41B
| $936K | ﹤0.01% |
5,526
-32,043
| -85% | -$5.81M |
|
|
FBMS
729
DELISTED
The First Bancshares, Inc.
FBMS
| $933K | ﹤0.01% |
29,148
+19,790
| +211% | +$641K |
|
730
Lennar Class B
LEN.B
$20.6B
| $921K | ﹤0.01% |
12,961
+82
| +0.6% | +$5.32K |
|
731
Aviat Networks
AVNW
$283M
| $905K | ﹤0.01% |
29,000
| – | – |
|
732
Chegg
CHGG
$86.9M
| $903K | ﹤0.01% |
35,733
+10,527
| +42% | +$268K |
|
733
Bloom Energy
BE
$71.4B
| $901K | ﹤0.01% |
47,147
+8,529
| +22% | +$167K |
|
734
CVB Financial
CVBF
$4.07B
| $900K | ﹤0.01% |
34,949
-1,411
| -4% | -$38.4K |
|
735
Marqeta
MQ
$1.66B
| $894K | ﹤0.01% |
36,572
-3,149
| -8% | -$86K |
|
736
Belden
BDC
$5.39B
| $889K | ﹤0.01% |
+12,370
| New | +$898K |
|
737
National Bank Holdings
NBHC
$1.94B
| $887K | ﹤0.01% |
21,081
-1,755
| -8% | -$75.8K |
|
738
Central Pacific Financial
CPF
$1B
| $883K | ﹤0.01% |
43,521
-5,859
| -12% | -$120K |
|
|
DVAX
739
DELISTED
Dynavax Technologies
DVAX
| $880K | ﹤0.01% |
82,709
+37,878
| +84% | +$440K |
|
|
KRTX
740
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $875K | ﹤0.01% |
4,451
-456
| -9% | -$97.8K |
|
|
BLUE
741
DELISTED
bluebird bio
BLUE
| $873K | ﹤0.01% |
+6,311
| New | +$889K |
|
742
WSFS Financial
WSFS
$4.17B
| $866K | ﹤0.01% |
19,103
-1,137
| -6% | -$53.5K |
|
|
HIBB
743
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $857K | ﹤0.01% |
12,561
+572
| +5% | +$35.7K |
|
744
Super Micro Computer
SMCI
$25.7B
| $853K | ﹤0.01% |
103,890
-22,540
| -18% | -$172K |
|
|
FISV
745
Fiserv Inc
FISV
$28.3B
| $848K | ﹤0.01% |
8,395
-68
| -0.8% | -$6.77K |
|
|
DQ
746
Daqo New Energy
DQ
$1B
| $846K | ﹤0.01% |
21,916
+397
| +2% | +$19.4K |
|
747
Webster Financial
WBS
$12.8B
| $843K | ﹤0.01% |
+17,802
| New | +$891K |
|
748
Atea Pharmaceuticals
AVIR
$412M
| $842K | ﹤0.01% |
175,048
-2,100
| -1% | -$10.6K |
|
|
OLPX
749
DELISTED
Olaplex Holdings
OLPX
| $841K | ﹤0.01% |
161,351
-18,641
| -10% | -$111K |
|
750
Protagonist Therapeutics
PTGX
$9.91B
| $840K | ﹤0.01% |
76,990
| – | – |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Los Angeles Capital Management held 1,324 positions worth $20.6B, up 6.8% from $19.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Los Angeles Capital Management's Q4 2022 filing shows 114 new, 401 increased, 595 reduced and 142 closed positions. Its largest new stake was Hologic: 435,924 shares worth $32.6M. The largest sale was KLA, an estimated $138M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 31% a quarter earlier, followed by Healthcare and Financials.
- Los Angeles Capital Management's largest Q4 2022 buy was Hologic: 435,924 shares worth $32.6M.
- Los Angeles Capital Management added most to US Bancorp in Q4 2022, an estimated $107M increase.
- Los Angeles Capital Management's biggest Q4 2022 reduction was KLA, cutting an estimated $138M.
- Los Angeles Capital Management fully exited Knight Transportation in Q4 2022, selling an estimated $31.6M.
- Los Angeles Capital Management's ten largest holdings make up 23% of its $20.6B portfolio in Q4 2022.
- Los Angeles Capital Management opened 114 new positions and closed 142 in Q4 2022.
- Los Angeles Capital Management's portfolio value rose 6.8% quarter-over-quarter to $20.6B.
Based on Los Angeles Capital Management's 13F filing for Q4 2022, filed 6 Feb 2023.